scholarly article | Q13442814 |
P356 | DOI | 10.1093/IBD/IZX105 |
P698 | PubMed publication ID | 29506124 |
P50 | author | Atsushi Sakuraba | Q51055396 |
P2093 | author name string | David T Rubin | |
Stephen B Hanauer | |||
Russell D Cohen | |||
Parita Patel | |||
Sushila Dalal | |||
Joel Pekow | |||
Laura H Raffals | |||
Andres Yarur | |||
Ira Hanan | |||
P2860 | cites work | Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. | Q53122367 |
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. | Q54007642 | ||
Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis1 1Gert Van Assche, Severine Vermeire, Geert D’Haens, and Paul Rutgeerts have been instrumental in the design of the study, trial man | Q57265461 | ||
Preliminary report: cyclosporin in treatment of severe active ulcerative colitis | Q68091416 | ||
Course of ulcerative colitis: analysis of changes in disease activity over years | Q72036054 | ||
Cyclosporin for severe ulcerative colitis: a user's guide | Q73747657 | ||
Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis | Q80269736 | ||
[Use of infliximab in ulcerative colitis] | Q80802092 | ||
Management of acute, severe ulcerative colitis | Q83275256 | ||
Once-daily budesonide MMX® extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study | Q84794233 | ||
Infliximab for induction and maintenance therapy for ulcerative colitis | Q28285876 | ||
Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long-term retrospective cohort study | Q33280166 | ||
Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis | Q34009451 | ||
Cyclosporine in severe ulcerative colitis refractory to steroid therapy | Q34060783 | ||
MANAGEMENT OF ACUTE SEVERE ULCERATIVE COLITIS: A CLINICAL UPDATE. | Q36167512 | ||
Complications of biological therapy for inflammatory bowel diseases | Q36327680 | ||
Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial | Q37196938 | ||
Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study | Q37600339 | ||
Management of severe ulcerative colitis: An up-to-date | Q40258181 | ||
Intravenous cyclosporin in ulcerative colitis: a five-year experience | Q41671378 | ||
Assessment of severity in colitis: a preliminary study | Q41988487 | ||
Changing referral patterns for surgical treatment of ulcerative colitis | Q42058628 | ||
Serum albumin concentration: a predictive factor of infliximab pharmacokinetics and clinical response in patients with ulcerative colitis. | Q43085148 | ||
Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis | Q43582796 | ||
Treatment of ulcerative colitis refractory to steroid therapy by oral microemulsion cyclosporine (Neoral). | Q43658939 | ||
Azathioprine without oral ciclosporin in the long-term maintenance of remission induced by intravenous ciclosporin in severe, steroid-refractory ulcerative colitis | Q44230091 | ||
Long-term results of low-dose intravenous ciclosporin for acute severe ulcerative colitis | Q44535154 | ||
Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. | Q46531976 | ||
Pharmacologic therapies for severe steroid refractory hospitalized ulcerative colitis: A network meta-analysis | Q48161573 | ||
P433 | issue | 6 | |
P921 | main subject | cyclosporine | Q367700 |
P304 | page(s) | 1291-1297 | |
P577 | publication date | 2018-05-01 | |
P1433 | published in | Inflammatory Bowel Diseases | Q15749161 |
P1476 | title | Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy | |
P478 | volume | 24 |
Search more.